Strength Seen in Isis Pharmaceuticals (ISIS): Stock Soars 14.1% - Analyst Blog
September 20 2013 - 9:00AM
Zacks
Isis Pharmaceuticals, Inc. (ISIS) was a big
mover last session, as the company saw its shares move higher by
over 14% on the day. The move came on the back of solid volume too,
as far more shares changed hands than in a normal session. The
uptrend is continuing for this biotechnology company, as the stock
surged more than 40% in the past one-month time period.
The company has seen 5 positive revisions in the past few weeks and
its earnings consensus has moved up over the past two months,
suggesting that more solid trading could be ahead for ISIS. So make
sure to keep an eye on this stock going forward to see if this
recent jump can turn into more strength down the road.
Isis Pharmaceuticals currently has a Zacks Rank #3 (Hold) and its
Earnings ESP is positive.
Some better performing biotechnology stocks include
Affymetrix Inc. (AFFX), Biogen Idec
Inc. (BIIB) and Gilead Sciences Inc.
(GILD). All these carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days. Click
to get this free report >>
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
GILEAD SCIENCES (GILD): Free Stock Analysis Report
ISIS PHARMACEUT (ISIS): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024